Yakult Honsha And OncoTherapy Science, Inc. To Team Up In R&D For New Antibody Drugs For Lung Cancer Treatments 
10/19/2005 5:11:05 PM

Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments. Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.